|
|
Article: CVS Caremark Praises FTC Report Supporting Pro-Consumer Approach to Biogeneric Competition
- Article from:
- U.S. Newswire
- Article date:
- June 11, 2009
CopyrightCopyright 2009 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: RETAILING EDITORS
Contact: Christine Cramer, +1-401-770-3317, ckcramer@cvs.com, or
Steve Campanini, +1-401-770-5005, slcampanini@cvs.com, both
Corporate Communications of CVS Caremark
WOONSOCKET, R.I., June 11 /PRNewswire/ -- CVS Caremark (NYSE:
CVS) today applauded a Federal Trade Commission (FTC) report issued
this week for its pro-consumer leadership in the debate about how to
create a legislative pathway for the approval of biogenerics that
reasonably balances innovation with competition.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO)
Dave Golding, R.Ph., Executive Vice President for Specialty
Pharmacy services at CVS Caremark, participated in an FTC Roundtable ...